The current valuation score of Opus Genetics Inc is 8.84, ranking 65 out of 157 in the Pharmaceuticals industry. Its current P/E ratio is -3.11, which is -311.59% below the recent high of 6.58 and -132.11% above the recent low of -7.21.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/S
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.